How to Short Sell a Biotech
Jun 30th, 2008 | By Dr. George Huang | Category: Stock Market InvestingEditor’s Note: Investors kill biotech stocks when the Food and Drug Administration (FDA) doesn’t approve a new drug. You can take advantage of Mr. Market’s overreaction and pick up good companies for cheap when this happens, says Dr. George Huang, editor of new Stansberry Research trading service the S&A FDA Report.